Vsee Health (VSEE) EBIAT (2023 - 2025)
Vsee Health's EBIAT history spans 3 years, with the latest figure at -$7.9 million for Q4 2025.
- For Q4 2025, EBIAT fell 144.7% year-over-year to -$7.9 million; the TTM value through Dec 2025 reached -$14.7 million, up 75.29%, while the annual FY2025 figure was -$14.7 million, 74.5% up from the prior year.
- EBIAT reached -$7.9 million in Q4 2025 per VSEE's latest filing, down from -$289745.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of $94750.0 in Q1 2024 to a low of -$53.9 million in Q3 2024.
- Average EBIAT over 3 years is -$6.9 million, with a median of -$2.5 million recorded in 2023.
- The largest YoY upside for EBIAT was 117.88% in 2024 against a maximum downside of 30314.72% in 2024.
- A 3-year view of EBIAT shows it stood at -$2.5 million in 2023, then fell by 28.01% to -$3.2 million in 2024, then crashed by 144.7% to -$7.9 million in 2025.
- Per Business Quant, the three most recent readings for VSEE's EBIAT are -$7.9 million (Q4 2025), -$289745.0 (Q3 2025), and -$2.6 million (Q2 2025).